SynthesisNeurocritical care2026
Systematic Review of Direct Hospital Costs Associated with Aneurysmal Subarachnoid Hemorrhage Management.
Synthesis in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAneurysmal subarachnoid hemorrhage (aSAH) is a severe condition associated with significant morbidity, mortality, and disability. In-hospital care of aSAH is complex and resource intensive, posing substantial financial challenges to health care systems. To support efficient resource allocation, health policy decision-making, and care optimization, this systematic review aimed to assess and synthesize literature on direct in-hospital costs of aSAH management.
methodsA comprehensive search was performed in July 2025 across PubMed, Medline, Web of Science, Cochrane Library, Emcare, Embase (Ovid), and PsycINFO to identify studies reporting direct in-hospital costs related to aSAH. Reporting completeness and risk of bias were assessed using the Consolidated Health Economic Evaluation Reporting Standards 2022 and the Joanna Briggs Institute checklists. Reported costs were narratively synthesized and converted to 2024 US dollars using the CCEMG-EPPI-Centre Cost Converter. In addition, a random-effects meta-analysis was conducted to compare in-hospital costs between surgical clipping and endovascular coiling.
resultsThe database search identified 1,591 articles, of which 30 were included. The average reporting completeness was 74% (range 46-91%) and methodological quality 76% (range 41-100%). Reported in-hospital costs ranged from $11,884 to $459,579 (median $68,711), being the highest in North America, followed by Europe and Asia. Costs as a percentage of gross domestic product per capita ranged from 35 to 639%. Key cost drivers included length of stay, clinical severity, and complications. The meta-analysis found no significant cost difference between clipping and coiling (mean difference $3,057, 95% confidence interval -$11,597 to $17,710).
conclusionsIn-hospital costs for aSAH management are substantial and vary widely due to differences in health care systems, study methodology, and clinical practices. The quality of economic evaluations remains inconsistent, underscoring the need for more standardized and transparent methodologies. As global health care spending increases, high-quality economic evidence is essential for equitable and sustainable care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.